Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,661 | -9,218 | -5,341 | -31,608 | -25,237 |
| Depreciation Amortization | 9 | 3 | 2 | 7 | 5 |
| Accounts receivable | 1,481 | 1,481 | 1,481 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,770 | -672 | 628 | 1,313 | 174 |
| Other Working Capital | -252 | 1,302 | 1,966 | 2,370 | 845 |
| Other Operating Activity | 859 | -482 | -1,905 | 10,324 | 11,332 |
| Operating Cash Flow | $-11,335 | $-7,586 | $-3,169 | $-17,595 | $-12,882 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,500 | -1,500 |
| Other Investing Activity | 0 | 0 | 0 | -1,500 | -1,500 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-1,500 | $-1,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,921 | 7,021 | 337 | 1,987 | 1,987 |
| Other Financing Activity | -111 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $6,809 | $7,021 | $337 | $1,987 | $1,987 |
| Beginning Cash Position | 12,106 | 12,106 | 12,106 | 29,214 | 29,214 |
| End Cash Position | 7,581 | 11,541 | 9,274 | 12,106 | 16,820 |
| Net Cash Flow | $-4,526 | $-565 | $-2,833 | $-17,108 | $-12,394 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,335 | -7,586 | -3,169 | -17,595 | -12,882 |
| Free Cash Flow | -11,335 | -7,586 | -3,169 | -17,595 | -12,882 |